Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Optimizing and reinforcing walking skills in people with severe multiple sclerosis using high-intensity circuit training and telerehabilitation.

Official title: Unravelling The Optimisation And Consolidation Of Motor Skills In People With Multiple Sclerosis With Severe Gait Impairment Via High Intensity Task Oriented Circuit Training: A Feasibility Study

Run by University Hospital of Ferrara · NCT07058896 · Data updated 2026-11-12

This trial will try a short program of high-intensity, task-focused circuit training followed by six months of telerehabilitation to improve walking and balance in people with progressive MS who have severe gait problems (EDSS ≥6.5).

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment18 (estimated)
SponsorUniversity Hospital of Ferrara
Academic / other
Locations1 site (Ferrara, FE)
StatusRecruiting
StartedOctober 28, 2024
Main results expectedOctober 31, 2025
Study endsOctober 31, 2025
Registry record updatedJuly 10, 2025
Trial IDNCT07058896 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with primary or secondary progressive MS, EDSS ≥6.5, MMSE >24, stable on medications for at least three months, and without major cardiopulmonary, renal, liver, psychiatric, or other neurological comorbidities.

Probably not a fit

People with significant medical comorbidities, cognitive impairment (MMSE ≤24), recent medication changes, pregnancy, or who cannot attend in-person sessions at the Ferrara site are unlikely to be eligible or to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with primary or secondary progressive MS, preserved cognition (MMSE >24), and marked gait impairment (EDSS ≥6.5) will complete a supervised high-intensity, task-oriented circuit training program (about 12 sessions) to practice and consolidate motor skills. After the supervised phase, participants will be offered a telerehabilitation program intended to maintain gains over a six-month follow-up. The study will monitor feasibility, safety, and changes in gait and balance using standardized outcome measures at baseline, post-intervention, and during follow-up. The intervention is delivered at Ferrara University Hospital with remote components for the maintenance phase.

Why it matters

Potential benefit: If successful, the approach could improve walking ability and balance in people with severe MS and help them keep those gains at home through telerehabilitation.

How similar studies have gone: Previous motor rehabilitation and high-intensity training studies have shown benefits for walking in people with MS, but evidence specifically for those with severe gait impairment and for sustaining gains via telerehabilitation is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of primary or secondary progressive multiple sclerosis according to the McDonald criteria.
* Mini-Mental State Examination (MMSE) score \> 24.
* Expanded Disability Status Scale (EDSS) score ≥ 6.5.

Exclusion Criteria:

* Presence of other psychiatric or neurological disorders.
* Cardiopulmonary, renal, or liver diseases.
* Pregnancy.
* Modifications in drug treatment within the last 3 months.

Where it's running

  • Ferrara University Hospital
    Ferrara, Fe, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.